A Surgical Window Trial Evaluating Medroxyprogesterone Acetate with or without Entinostat in Patients with Endometrial Cancer and Validation of Biomarkers of Cellular Response.

Saved in:
Bibliographic Details
Title: A Surgical Window Trial Evaluating Medroxyprogesterone Acetate with or without Entinostat in Patients with Endometrial Cancer and Validation of Biomarkers of Cellular Response.
Authors: Duska LR; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Virginia School of Medicine, Charlottesville, Virginia. lduska@virginia.edu., Filiaci VL; NRG Oncology SDMC, CTD Division, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Walker JL; Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Holman LL; Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Hill EK; Department of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, Iowa City, Iowa., Moore RG; Department of Obstetrics and Gynecology, Wilmont Cancer Institute, University of Rochester Medical Center, Rochester, New York., Ring KL; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Virginia School of Medicine, Charlottesville, Virginia., Pearl ML; Department of Obstetrics, Gynecology and Reproductive Medicine, Division of Gynecologic Oncology, Stony Brook University Medical Center, Stony Brook, New York., Muller CY; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of New Mexico, Albuquerque, New Mexico., Kushnir CL; Department of Obstetrics and Gynecology, Women's Cancer Center, Las Vegas, Nevada., Lankes HA; NRG Oncology, Operations Center-Philadelphia East, Philadelphia, Pennsylvania.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, Columbus, Ohio., Samuelson MI; Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, Iowa., Carrick KS; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas., Rajan A; Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, Iowa., Rodgers WH; Department of Pathology, New York Hospital Queens, Weill Medical College of Cornell University, Flushing, New York., Kohn EC; Cancer Therapy Evaluation Program, NCI, Rockville, Maryland., Piekarz R; Cancer Therapy Evaluation Program, NCI, Rockville, Maryland., Leslie KK; Department of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, Iowa City, Iowa.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 May 15; Vol. 27 (10), pp. 2734-2741. Date of Electronic Publication: 2021 Mar 25.
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-20-4618